These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 34694152

  • 1. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
    Che Y, Buddensieck C, Albers P, Lusch A, Winter C, Siemer RG, Hiester A.
    J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
    [Abstract] [Full Text] [Related]

  • 2. [In which marker-positive patients with germ cell tumors is residual tumor resection of value?].
    Weinknecht S, Hartmann M, Weissbach L.
    Urologe A; 1998 Nov; 37(6):621-4. PubMed ID: 9887490
    [Abstract] [Full Text] [Related]

  • 3. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.
    J Surg Oncol; 2006 Dec 01; 94(7):619-23. PubMed ID: 17111392
    [Abstract] [Full Text] [Related]

  • 4. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
    Wood DP, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ.
    Cancer; 1992 Nov 01; 70(9):2354-7. PubMed ID: 1382832
    [Abstract] [Full Text] [Related]

  • 5. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

  • 6. Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection.
    Che Y, Wöltjen C, Lusch A, Winter C, Trainer S, Schirren M, Sponholz S, Knoefel WT, Albers P, Hiester A.
    World J Surg Oncol; 2024 Jul 17; 22(1):185. PubMed ID: 39020389
    [Abstract] [Full Text] [Related]

  • 7. Retroperitoneal lymph node dissection in the setting of elevated markers.
    Lakes J, Lusch A, Nini A, Albers P.
    Curr Opin Urol; 2018 Sep 17; 28(5):435-439. PubMed ID: 30004909
    [Abstract] [Full Text] [Related]

  • 8. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
    Vugrin D, Friedman A, Whitmore WF.
    Cancer; 1984 Mar 15; 53(6):1440-5. PubMed ID: 6198071
    [Abstract] [Full Text] [Related]

  • 9. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor.
    Ghodoussipour S, Daneshmand S.
    Urol Clin North Am; 2019 Aug 15; 46(3):389-398. PubMed ID: 31277733
    [Abstract] [Full Text] [Related]

  • 10. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S.
    Lancet Oncol; 2014 Dec 15; 15(13):1442-1450. PubMed ID: 25456363
    [Abstract] [Full Text] [Related]

  • 11. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
    Paffenholz P, Pfister D, Heidenreich A.
    Urologe A; 2016 May 15; 55(5):632-40. PubMed ID: 26820659
    [Abstract] [Full Text] [Related]

  • 12. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels.
    Speir RW, Calaway AC, Einhorn LH, Foster RS, Cary C.
    Urol Oncol; 2020 Aug 15; 38(8):687.e19-687.e23. PubMed ID: 32448503
    [Abstract] [Full Text] [Related]

  • 13. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
    Vuky J, Bains M, Bacik J, Higgins G, Bajorin DF, Mazumdar M, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2001 Feb 01; 19(3):682-8. PubMed ID: 11157018
    [Abstract] [Full Text] [Related]

  • 14. Postchemotherapy residual masses in germ cell tumor patients: our experience.
    Morelli F, Tozzi L, Setola P, Bisceglia M, Barbini VR, Maiello E.
    Ann Oncol; 2006 Jun 01; 17 Suppl 7():vii132-6. PubMed ID: 16760276
    [Abstract] [Full Text] [Related]

  • 15. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
    Schneider BP, Kesler KA, Brooks JA, Yiannoutsos C, Einhorn LH.
    J Clin Oncol; 2004 Apr 01; 22(7):1195-200. PubMed ID: 15051766
    [Abstract] [Full Text] [Related]

  • 16. [High-dose chemotherapy and residual tumor resection in male germ cell tumors].
    Lorch A, Albers P, Winter C, Beyer J.
    Urologe A; 2011 Sep 01; 50(9):1047-54. PubMed ID: 21845425
    [Abstract] [Full Text] [Related]

  • 17. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors.
    Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C.
    Ann Oncol; 1997 Jun 01; 8(6):531-8. PubMed ID: 9261521
    [Abstract] [Full Text] [Related]

  • 18. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
    Kawaguchi T, Kumabe T, Kanamori M, Saito R, Yamashita Y, Sonoda Y, Watanabe M, Tominaga T.
    J Neurooncol; 2011 Sep 01; 104(3):779-87. PubMed ID: 21359564
    [Abstract] [Full Text] [Related]

  • 19. Late relapsing germ cell tumors with elevated tumor markers.
    Che Y, Lusch A, Winter C, Große Siemer R, Buddensieck C, Albers P, Hiester A.
    World J Urol; 2022 Feb 01; 40(2):363-371. PubMed ID: 34518930
    [Abstract] [Full Text] [Related]

  • 20. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
    Miki T, Saki S, Kotake T.
    Hinyokika Kiyo; 1994 Oct 01; 40(10):951-5. PubMed ID: 7992713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.